Abstract Severe aplastic anemia (SAA) is a life-threatening hematological disorder, and the optimal treatment for patients aged ≥40 years remains controversial. This retrospective study aims to conduct a comparative analysis of the efficacy of immunosuppressive therapy (IST) versus haploidentical hematopoietic stem cel...
Myelodysplastic syndromes (MDS) are clonal disorders with high risk of progression to acute myeloid leukemia (AML). Allogeneic haematopoietic stem cell transplantation (allo‐HSCT), including haploidentical HSCT (haplo‐HSCT), is the only curative option. Age‐stratified selection of conditioning regimens based on organ r...
Ning Wu, Meng Lv, Xiao-Dong Mo et al.· Hematological Oncology· 0 citations
Objective Cytomegalovirus (CMV) infection can cause severe morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Letermovir is recommended as CMV prophylaxis for allo-HSCT recipients. This study aimed to further confirm the efficacy of letermovir prophylaxis in d...
Yi Xia, Qi Wen, Jing Liu et al.· Frontiers in Immunology· 0 citations
OBJECTIVES
EBV reactivation after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is typically monitored by plasma viral load, but this fails to capture cellular reservoirs. Lineage-specific testing, though usually performed in high-risk patients, may identify biologically distinct disease states. We aim...
Zhi-Fan Zhao, Zhuo-Jun Liu, Qiang Huang et al.· Clinical Microbiology and In...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.